{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:32:24Z","timestamp":1774053144343,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s11239-016-1427-3","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T08:35:57Z","timestamp":1474878957000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation"],"prefix":"10.1007","volume":"43","author":[{"given":"Yee Cheng","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinmei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Blann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"issue":"10","key":"1427_CR1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28(10):973\u2013977","journal-title":"Neurology"},{"issue":"2","key":"1427_CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.15-1095","volume":"149","author":"Y Yamashita","year":"2016","unstructured":"Yamashita Y, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H et al (2016) Clinical characteristics and outcomes in extreme elderly (age \u226585) Japanese patients with atrial fibrillation: the Fushimi AF registry. Chest 149(2):401\u2013412","journal-title":"Chest"},{"issue":"10","key":"1427_CR3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","volume":"119","author":"AS Go","year":"2009","unstructured":"Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L et al (2009) Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 119(10):1363\u20131369","journal-title":"Circulation"},{"key":"1427_CR4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","volume":"367","author":"JB Olesen","year":"2012","unstructured":"Olesen JB, Lip GY, Kamper AL, Hommel K, Kober L, Lane DA et al (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. New Engl J Med 367:625\u2013635","journal-title":"New Engl J Med"},{"key":"1427_CR5","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","volume":"64","author":"AN Bonde","year":"2014","unstructured":"Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K et al (2014) Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. J Am Coll Cardiol 64:2471\u20132482","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1427_CR6","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1681\/ASN.2005050535","volume":"16","author":"N Amabile","year":"2005","unstructured":"Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J et al (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16(11):3381\u20133388","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1427_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH13-11-0937","volume":"111","author":"E Shantsila","year":"2014","unstructured":"Shantsila E, Montoro-Garcia S, Gallego P, Lip GY (2014) Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thromb Haemostasis 111(6):1009\u20131014","journal-title":"Thromb Haemostasis"},{"issue":"1","key":"1427_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.32326","volume":"23","author":"S Nomura","year":"2016","unstructured":"Nomura S (2016) Microparticle and atherothrombotic diseases. J Atheroscler Thromb 23(1):1\u20139","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"1427_CR9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH06-06-0313","volume":"97","author":"EI Sinauridze","year":"2007","unstructured":"Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV et al (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Hemostasis 97(3):425\u2013434","journal-title":"Thromb Hemostasis"},{"issue":"6","key":"1427_CR10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1538-7836.2005.01384.x","volume":"3","author":"W Jy","year":"2005","unstructured":"Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER et al (2005) Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor\/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemostasis 3(6):1301\u20131308","journal-title":"J Thromb Haemostasis"},{"issue":"11","key":"1427_CR11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20021868","volume":"197","author":"S Falati","year":"2003","unstructured":"Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E et al (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197(11):1585\u20131598","journal-title":"J Exp Med"},{"issue":"5","key":"1427_CR12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2004-03-1095","volume":"106","author":"I Del Conde","year":"2005","unstructured":"Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106(5):1604\u20131611","journal-title":"Blood"},{"issue":"1","key":"1427_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1160\/TH04-06-0393","volume":"93","author":"B Steppich","year":"2005","unstructured":"Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schomig A, Ott I (2005) Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemostasis 93(1):35\u201339","journal-title":"Thromb Haemostasis"},{"issue":"5","key":"1427_CR14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/ndt\/gfr573","volume":"27","author":"N Amabile","year":"2012","unstructured":"Amabile N, Guerin AP, Tedgui A, Boulanger CM, London GM (2012) Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dialysis Transplant 27(5):1873\u20131880","journal-title":"Nephrol Dialysis Transplant"},{"issue":"3","key":"1427_CR15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1378\/chest.06-2039","volume":"131","author":"A Choudhury","year":"2007","unstructured":"Choudhury A, Chung I, Blann AD, Lip GY (2007) Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to P-selectin and antithrombotic therapy. Chest 131(3):809\u2013815","journal-title":"Chest"},{"issue":"2","key":"1427_CR16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2013.03.031","volume":"168","author":"L Jesel","year":"2013","unstructured":"Jesel L, Abbas M, Toti F, Cohen A, Arentz T, Morel O (2013) Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity. Int J Cardiol 168(2):660\u2013669","journal-title":"Int J Cardiol"},{"key":"1427_CR17","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","volume":"24","author":"AD Blann","year":"2003","unstructured":"Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166\u20132179","journal-title":"Eur Heart J"},{"key":"1427_CR18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1160\/TH02-09-0083","volume":"90","author":"V Rold\u00e1n","year":"2003","unstructured":"Rold\u00e1n V, Mar\u00edn F, Lip GY, Blann AD (2003) Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost 90:1007\u20131020","journal-title":"Thromb Haemost"},{"key":"1427_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"issue":"3","key":"1427_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1538-7836.2011.04610.x","volume":"10","author":"R Lacroix","year":"2012","unstructured":"Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J et al (2012) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 10(3):437\u2013446","journal-title":"J Thromb Haemost"},{"key":"1427_CR21","unstructured":"Kidney Disease Improving global outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int (Suppl 3):1\u2013150"},{"issue":"2","key":"1427_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1160\/TH12-02-0120","volume":"108","author":"S Montoro-Garcia","year":"2012","unstructured":"Montoro-Garcia S, Shantsila E, Orenes-Pinero E, Lozano ML, Lip GY (2012) An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium. Thromb Haemostasis 108(2):373\u2013383","journal-title":"Thromb Haemostasis"},{"key":"1427_CR23","volume-title":"Practical statistics for medical research","author":"DG Altman","year":"1991","unstructured":"Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London"},{"key":"1427_CR24","doi-asserted-by":"crossref","first-page":"c47","DOI":"10.1159\/000086221","volume":"101","author":"K Kundhal","year":"2005","unstructured":"Kundhal K, Lok CE (2005) Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract 101:c47\u201352","journal-title":"Nephron Clin Pract"},{"key":"1427_CR25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/ndt\/gfv337","volume":"31","author":"T Almquist","year":"2016","unstructured":"Almquist T, Mobarrez F, Jacobson SH, Wallen H, Hjemdahl P (2016) Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Nephrol Dial Transplant 31:944\u2013952","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1427_CR26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","volume":"4","author":"V Faure","year":"2006","unstructured":"Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y et al (2006) Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4(3):566\u2013573","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1427_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5551\/jat.26658","volume":"22","author":"YL Chen","year":"2015","unstructured":"Chen YL, Chen CH, Wallace CG, Wang HT, Yang CC, Yip HK (2015) Levels of circulating microparticles in patients with chronic cardiorenal disease. J Atherosclerosis Thrombosis 22(3):247\u2013256","journal-title":"J Atherosclerosis Thrombosis"},{"issue":"9","key":"1427_CR28","first-page":"16704","volume":"8","author":"GY Lu","year":"2015","unstructured":"Lu GY, Xu RJ, Zhang SH, Qiao Q, Shen L, Li M et al (2015) Alteration of circulatory platelet microparticles and endothelial microparticles in patients with chronic kidney disease. Int J Clin Exp Med 8(9):16704\u201316708","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"1427_CR29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0038-1646488","volume":"66","author":"MJ Metzelaar","year":"1991","unstructured":"Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK (1991) Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost 66(6):700\u2013707","journal-title":"Thromb Haemost"},{"issue":"30","key":"1427_CR30","doi-asserted-by":"crossref","first-page":"20836","DOI":"10.1074\/jbc.M114.557454","volume":"289","author":"H Mei","year":"2014","unstructured":"Mei H, Campbell JM, Paddock CM, Lertkiatmongkol P, Mosesson MW, Albrecht R et al (2014) Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem 289(30):20836\u201320844","journal-title":"J Biol Chem"},{"issue":"3","key":"1427_CR31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-013-1779-3","volume":"355","author":"JR Privratsky","year":"2014","unstructured":"Privratsky JR, Newman PJ (2014) PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res 355(3):607\u2013619","journal-title":"Cell Tissue Res"},{"issue":"19","key":"1427_CR32","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2013-04-499558","volume":"122","author":"J Kellermair","year":"2013","unstructured":"Kellermair J, Redwan B, Alias S, Jabkowski J, Panzenboeck A, Kellermair L et al (2013) Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution. Blood 122(19):3376\u20133384","journal-title":"Blood"},{"issue":"9","key":"1427_CR33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjhyper.2007.04.005","volume":"20","author":"JM Wang","year":"2007","unstructured":"Wang JM, Huang YJ, Wang Y, Xu MG, Wang LC, Wang SM et al (2007) Increased circulating CD31+\/CD42\u2212 microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 20(9):957\u2013964","journal-title":"Am J Hypertens"},{"key":"1427_CR34","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0002-8703(03)00103-0","volume":"145","author":"L Bernal-Mizrachi","year":"2003","unstructured":"Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL et al (2003) High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145:962\u2013970","journal-title":"Am Heart J"},{"issue":"1","key":"1427_CR35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.ATV.0000191634.13057.15","volume":"26","author":"N Werner","year":"2006","unstructured":"Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G (2006) Circulating CD31+\/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscl Thromb Vascular Biol 26(1):112\u2013116","journal-title":"Arterioscl Thromb Vascular Biol"},{"key":"1427_CR36","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","volume":"32","author":"JM Sinning","year":"2011","unstructured":"Sinning JM, Losch J, Walenta K, B\u00f6hm M, Nickenig G, Werner N (2011) Circulating CD31+\/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 32:2034\u20132041","journal-title":"Eur Heart J"},{"key":"1427_CR37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.amjcard.2007.04.040","volume":"100","author":"S Ederhy","year":"2007","unstructured":"Ederhy S, Di Angelantonio E, Mallat Z, Hugel B, Janower S, Meuleman C et al (2007) Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. Am J Cardiol 100:989\u2013994","journal-title":"Am J Cardiol"},{"key":"1427_CR38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5500\/wjt.v5.i4.267","volume":"5","author":"I Dursun","year":"2015","unstructured":"Dursun I, Yel S, Unsur E (2015) Dynamics of circulating microparticles in chronic kidney disease and transplantation: is it really reliable marker?. World J Transplant 5:267\u2013275","journal-title":"World J Transplant"},{"issue":"2","key":"1427_CR39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2004.03.067","volume":"44","author":"SK Nadar","year":"2004","unstructured":"Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY (2004) Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 44(2):415\u2013422","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1427_CR40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-2141.2003.04320.x","volume":"121","author":"GJ Caine","year":"2003","unstructured":"Caine GJ, Blann AD (2003) Soluble P-selectin should be measured in citrated plasma, not in serum. Br J Haematol 121(3):530\u2013532","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1427-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1427-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1427-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T20:47:19Z","timestamp":1568407639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1427-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1427-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]}}}